TCI Wealth Advisors, Inc. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 425 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$18,217
-27.4%
477
+8.2%
0.00%
-33.3%
Q4 2022$25,093
+47.6%
441
+0.2%
0.00%0.0%
Q3 2022$17,000
-10.5%
440
+1.4%
0.00%0.0%
Q2 2022$19,000
+11.8%
4340.0%0.00%0.0%
Q1 2022$17,0000.0%4340.0%0.00%0.0%
Q4 2021$17,000
+70.0%
434
+83.1%
0.00%
+50.0%
Q3 2021$10,000
+150.0%
237
+189.0%
0.00%
+100.0%
Q2 2021$4,000
-33.3%
82
-44.6%
0.00%
-66.7%
Q1 2021$6,000148
+7300.0%
0.00%
Q4 2020$0
-100.0%
2
-99.6%
0.00%
-100.0%
Q1 2015$7,0005000.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders